Shares trading under the ticker symbol NAGE represent ownership in Niagen Bioscience (formerly ChromaDex Corporation), a bioscience enterprise dedicated to healthy aging research and nutritional science. The company develops, manufactures, and markets proprietary ingredients like Niagen (nicotinamide riboside) directly to consumers and global supplement brands. Public investors utilize this equity to gain financial exposure to the growing consumer health, longevity, and biotechnology markets.